MULTIPLE ENDOCRINE NEOPLASIA, TYPE 1
Clinical trials for MULTIPLE ENDOCRINE NEOPLASIA, TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE ENDOCRINE NEOPLASIA, TYPE 1 trials appear
Sign up with your email to follow new studies for MULTIPLE ENDOCRINE NEOPLASIA, TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug cocktail aims to shrink Hard-to-Treat carcinoid tumors
Disease control OngoingThis Phase II trial tests whether combining lenvatinib and everolimus can shrink or slow advanced carcinoid tumors that cannot be removed by surgery. The study enrolls 36 adults with confirmed unresectable carcinoid tumors. Both drugs are taken orally and work by blocking enzymes…
Matched conditions: MULTIPLE ENDOCRINE NEOPLASIA, TYPE 1
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Can Full-Body scans spot cancer early in High-Risk families?
Diagnosis OngoingThis study is testing whether whole body MRI scans can help find cancers early in children and adults with Li-Fraumeni syndrome, a genetic condition that greatly raises cancer risk. About 150 participants will receive annual whole body MRI scans for four years to see if they keep…
Matched conditions: MULTIPLE ENDOCRINE NEOPLASIA, TYPE 1
Phase: NA • Sponsor: Dana-Farber Cancer Institute • Aim: Diagnosis
Last updated Jun 27, 2026 08:08 UTC
-
Researchers launch registry to track rare endocrine tumors
Knowledge-focused OngoingThis study gathers health questionnaires from up to 1,500 people with multiple endocrine neoplasia (MEN1 or MEN2) and their close relatives. The goal is to build a database that helps researchers better understand these rare inherited conditions. No new treatments or procedures a…
Matched conditions: MULTIPLE ENDOCRINE NEOPLASIA, TYPE 1
Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC